Your browser doesn't support javascript.
loading
Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response
Liang Zhang; Yao Jiang; Jinhang He; Junyu Chen; Ruoyao Qi; Lunzhi Yuan; Tiange Shao; Congjie Chen; Yaode Chen; Xijing Wang; Xing Lei; Qingxiang Gao; Chunlan Zhuang; Ming Zhou; Jian Ma; Wei Liu; Man Yang; Rao Fu; Yangtao Wu; Feng Chen; Hualong Xiong; Meifeng Nie; Yiyi Chen; Kun Wu; Mujing Fang; Yingbin Wang; Zizheng Zheng; Shoujie Huang; Shengxiang Ge; Shih-Chin Cheng; Huachen Zhu; Tong Chen; Quan Yuan; Ting Wu; Jun Zhang; Yixin Chen; Tianying Zhang; Hai Qi; Yi Guan; Ningshao Xia.
Affiliation
  • Liang Zhang; Xiamen University
  • Yao Jiang; Xiamen University
  • Jinhang He; Xiamen University
  • Junyu Chen; Xiamen University
  • Ruoyao Qi; Xiamen University
  • Lunzhi Yuan; Xiamen University
  • Tiange Shao; Tsinghua University
  • Congjie Chen; Xiamen University
  • Yaode Chen; Xiamen University
  • Xijing Wang; Xiamen University
  • Xing Lei; Xiamen University
  • Qingxiang Gao; Xiamen University
  • Chunlan Zhuang; Xiamen University
  • Ming Zhou; Xiamen University
  • Jian Ma; Xiamen University
  • Wei Liu; Xiamen University
  • Man Yang; Xiamen University
  • Rao Fu; Xiamen University
  • Yangtao Wu; Xiamen University
  • Feng Chen; Xiamen University
  • Hualong Xiong; Xiamen University
  • Meifeng Nie; Xiamen University
  • Yiyi Chen; Xiamen University
  • Kun Wu; Xiamen University
  • Mujing Fang; Xiamen University
  • Yingbin Wang; Xiamen University
  • Zizheng Zheng; Xiamen University
  • Shoujie Huang; Xiamen University
  • Shengxiang Ge; Xiamen University
  • Shih-Chin Cheng; Xiamen University
  • Huachen Zhu; The University of Hong Kong
  • Tong Chen; Xiamen University
  • Quan Yuan; Xiamen University
  • Ting Wu; Xiamen University
  • Jun Zhang; Xiamen University
  • Yixin Chen; Xiamen University
  • Tianying Zhang; School of Public Health, Xiamen University
  • Hai Qi; Tsinghua University
  • Yi Guan; The University of Hong Kong
  • Ningshao Xia; Xiamen University
Preprint in En | PREPRINT-BIORXIV | ID: ppbiorxiv-510566
ABSTRACT
The emergence of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) variants and "anatomical escape" characteristics threaten the effectiveness of current coronavirus disease (COVID-19) vaccines. There is an urgent need to understand the immunological mechanism of broad-spectrum respiratory tract protection to guide broader vaccines development. In this study, we investigated immune responses induced by an NS1-deleted influenza virus vectored intranasal COVID-19 vaccine (dNS1-RBD) which provides broad-spectrum protection against SARS-CoV-2 variants. Intranasal delivery of dNS1-RBD induced innate immunity, trained immunity and tissue-resident memory T cells covering the upper and lower respiratory tract. It restrained the inflammatory response by suppressing early phase viral load post SARS-CoV-2 challenge and attenuating pro-inflammatory cytokine (IL-6, IL-1B, and IFN-{gamma}) levels, thereby reducing excess immune-induced tissue injury compared with the control group. By inducing local cellular immunity and trained immunity, intranasal delivery of NS1-deleted influenza virus vectored vaccine represents a broad-spectrum COVID-19 vaccine strategy to reduce disease burden.
License
cc_by_nc_nd
Full text: 1 Collection: 09-preprints Database: PREPRINT-BIORXIV Type of study: Experimental_studies Language: En Year: 2022 Document type: Preprint
Full text: 1 Collection: 09-preprints Database: PREPRINT-BIORXIV Type of study: Experimental_studies Language: En Year: 2022 Document type: Preprint
...